Working to Improve Immunotherapy for Lung Cancer

Working to Improve Immunotherapy for Lung Cancer

Working to Improve Immunotherapy for Lung CancerPosted on January 30th, 2020 by Dr. Francis CollinsCredit: Xiaodong Zhu, Fred Hutchinson Cancer Research Center, SeattleFor those who track cancer statistics, this year started off on a positive note with word that lung cancer deaths continue to decline in the United States [1]. This revolutionary approach has dramatically changed the treatment landscape for the most common type of lung cancer, non-small cell lung cancer (NSCLC). In the image on the left, large swaths of T cells (light blue) have infiltrated the cancer cells (white specks). This year, January brought encouraging news about decreasing deaths from lung cancer. Links:Non-Small Cell Lung Cancer Treatment (PDQ®)–Patient Version (National Cancer Institute/NIH)Spotlight on McGarry Houghton (Fred Hutchinson Cancer Research Center, Seattle)Houghton Lab (Fred Hutchinson Cancer Research Center)NIH Support: National Cancer Institute

About Us

At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.

Subscribe to our newsletter!